Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial.

Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M; Cholesterol and Recurrent Events (CARE) Trial Investigators..

BMJ. 2006 Jun 17;332(7555):1426. Epub 2006 May 19.

2.

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.

Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.

3.

The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients.

Moukarbel GV, Yu ZF, Dickstein K, Hou YR, Wittes JT, McMurray JJ, Pitt B, Zannad F, Pfeffer MA, Solomon SD.

Eur J Heart Fail. 2014 Mar;16(3):289-99. doi: 10.1002/ejhf.11. Epub 2013 Dec 6.

4.

Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes Study.

Lin CC, Chen CC, Kung PT, Li CI, Yang SY, Liu CS, Lin WY, Lee CC, Li TC, Kardia SL.

Cardiovasc Diabetol. 2012 Oct 19;11:131. doi: 10.1186/1475-2840-11-131.

5.

Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.

Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC.

Am Heart J. 2009 Apr;157(4):688-94. doi: 10.1016/j.ahj.2009.01.009. Epub 2009 Mar 6.

PMID:
19332197
6.

Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in Japan.

Nagata M, Ninomiya T, Kiyohara Y, Murakami Y, Irie F, Sairenchi T, Miura K, Okamura T, Ueshima H; EPOCH-JAPAN Research Group..

Am J Epidemiol. 2013 Jul 1;178(1):1-11. doi: 10.1093/aje/kws447. Epub 2013 Jun 9.

PMID:
23752917
7.

Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population.

Oh SW, Baek SH, Kim YC, Goo HS, Heo NJ, Na KY, Chae DW, Kim S, Chin HJ.

Nephrol Dial Transplant. 2012 Jun;27(6):2284-90. doi: 10.1093/ndt/gfr622. Epub 2011 Dec 1.

PMID:
22140122
8.

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group..

Ann Intern Med. 2006 Feb 7;144(3):172-80.

PMID:
16461961
9.

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA.

N Engl J Med. 2004 Sep 23;351(13):1285-95.

10.

Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).

Mercado N, Brugts JJ, Ix JH, Shlipak MG, Dixon SR, Gersh BJ, Lemos PA, Guarneri M, Teirstein PS, Wijns W, Serruys PW, Boersma E, O'Neill WW.

Am J Cardiol. 2008 Nov 1;102(9):1151-5. doi: 10.1016/j.amjcard.2008.06.035. Epub 2008 Aug 9.

PMID:
18940282
11.

Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.

Peters R, Beckett N, Poulter R, Burch L, Narkiewicz K, Fagard R, Nitsch D, Wang N, Li M, Fletcher A, Bulpitt C.

Age Ageing. 2013 Mar;42(2):253-8. doi: 10.1093/ageing/afs109. Epub 2012 Aug 21.

PMID:
22910302
12.

Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H; TREAT Investigators..

Am J Kidney Dis. 2009 Jul;54(1):59-69. doi: 10.1053/j.ajkd.2009.04.008. Epub 2009 Jun 5.

PMID:
19501439
13.

Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study.

Zambon S, Maggi S, Zanoni S, Romanato G, Noale M, Corti MC, Sartori L, Musacchio E, Baggio G, Sergi G, Crepaldi G, Manzato E.

Atherosclerosis. 2012 Jan;220(1):201-7. doi: 10.1016/j.atherosclerosis.2011.09.023. Epub 2011 Sep 22.

PMID:
22018644
14.

Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.

Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.

Am J Kidney Dis. 2009 Apr;53(4):606-16. doi: 10.1053/j.ajkd.2008.11.026. Epub 2009 Feb 12.

PMID:
19216016
15.
17.

Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria.

Tonelli M, Klarenbach SW, Lloyd AM, James MT, Bello AK, Manns BJ, Hemmelgarn BR.

Kidney Int. 2011 Dec;80(12):1306-14. doi: 10.1038/ki.2011.280. Epub 2011 Aug 17.

18.

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD.

Circulation. 2004 Dec 14;110(24):3667-73. Epub 2004 Nov 29.

19.

Effect of pravastatin on cardiovascular events in people with chronic kidney disease.

Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M.

Circulation. 2004 Sep 21;110(12):1557-63. Epub 2004 Sep 13. Review.

20.

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.

Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol And Recurrent Events Trial Investigators..

Circulation. 2005 Oct 25;112(17):2627-33. Erratum in: Circulation. 2007 Dec 4;116(23):e556.

Supplemental Content

Support Center